FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CONDON DENNIS E 		2. Issuer Name and Ticker or Trading Symbol

BIOFORM MEDICAL INC [ BFRM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Pres & Chief Business Officer
(Last)          (First)          (Middle)

1875 SOUTH GRANT STREET, SUITE 110 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/22/2009
(Street)

SAN MATEO, CA 94402
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $1.12   1/22/2009     A     140000         (1) 1/22/2019   Common Stock   140000     (2) 140000   D    
Employee Stock Option (Right to Buy)   $3.71   1/22/2009     D        140000      (3) 7/9/2018   Common Stock   140000     (2) 0   D    
Employee Stock Option (Right to Buy)   $1.12   1/22/2009     A     450000         (1) 1/22/2019   Common Stock   450000     (5) 450000   D    
Employee Stock Option (Right to Buy)   $7.30   1/22/2009     D        450000      (4) 7/25/2017   Common Stock   450000     (5) 0   D    
Employee Stock Option (Right to Buy)   $1.12   1/22/2009     A     13000         (1) 1/22/2019   Common Stock   13000     (7) 13000   D    
Employee Stock Option (Right to Buy)   $4.50   1/22/2009     D        13000      (6) 2/1/2017   Common Stock   13000     (7) 0   D    

Explanation of Responses:
( 1)  The shares subject to vest and become exercisable as to 1/4 of the shares on 01/22/2010 and each anniversary thereof.
( 2)  The reporting person agreed to cancellation of an option granted to him on 07/09/2008, in exchange for a new option having a lower exercise price.
( 3)  The shares subject to option vested and became exercisable as to 1/4 of the shares on 07/09/2009 and each anniversary thereof.
( 4)  The shares subject to option vested and became exercisable as to 12/48 of the shares on 06/11/2008 and 1/48 per month thereafter.
( 5)  The reporting person agreed to cancellation of an option granted to him on 07/25/2007, in exchange for a new option having a lower exercise price.
( 6)  The shares subject to option vested and became exercisable as to 1/3 of the shares on 02/01/2008 and each anniversary thereof.
( 7)  The reporting person agreed to cancellation of an option granted to him on 02/01/2007, in exchange for a new option having a lower exercise price.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
CONDON DENNIS E
1875 SOUTH GRANT STREET, SUITE 110
SAN MATEO, CA 94402

Pres & Chief Business Officer

Signatures
/s/ Dennis E. Condon 1/26/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Bioform Medical (MM) Charts.
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Bioform Medical (MM) Charts.